Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2000
03/16/2000WO2000014210A1 Systemic carnitine deficiency gene and utilization thereof
03/16/2000WO2000014198A2 Isolation of human pemt2 gene and methods for diagnosing and treating liver disorders
03/16/2000WO2000014113A2 Method of stimulating prosaposin receptor activity
03/16/2000WO2000014106A1 Novel bag proteins and nucleic acid molecules encoding them
03/16/2000WO2000014103A1 Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins
03/16/2000WO2000013706A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
03/16/2000WO2000013703A2 Methods of treating hypertension and compositions for use therein
03/16/2000WO2000013702A2 Use of an angiogenic factor for the treatment of microvascular angiopathies
03/16/2000WO2000013694A1 Gcp
03/16/2000WO2000013677A1 Nanogel networks and biological agent composition thereof
03/16/2000WO2000006696A3 Method for the modulation of function of transcription factors
03/16/2000WO2000002897A3 Delta cleavage products and methods based thereon
03/16/2000WO2000000628B1 Replication-defective recombinant adenovirus with mutated major late promoter
03/16/2000WO1999065937A9 Truncated apaf-1 and methods of use thereof
03/16/2000WO1999060131A3 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
03/16/2000WO1999058559B1 Factors affecting tumor necrosis factor receptor releasing enzyme activity
03/16/2000WO1999050403A9 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
03/16/2000WO1999046385A3 Compositions and methods for the treatment and prevention of metastatic disorders
03/16/2000DE19845434C1 Tissue binding peptides and related nucleotide sequences useful for tissue specific gene transfer
03/16/2000DE19841941A1 A novel metabotropic receptor complex from the central nervous system, related coding sequences and methods of identifying binding substances, ligands and interactions with other proteins
03/16/2000CA2346430A1 Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins
03/16/2000CA2343156A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof
03/16/2000CA2342800A1 Nanogel networks and biological agent composition thereof
03/16/2000CA2342284A1 Methylation of plasmid vectors
03/16/2000CA2342280A1 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
03/16/2000CA2342027A1 Novel bag proteins and nucleic acid molecules encoding them
03/16/2000CA2341782A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
03/16/2000CA2341777A1 Neutral amino acid transporter and gene thereof
03/16/2000CA2341349A1 Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof
03/16/2000CA2341325A1 Method of stimulating prosaposin receptor activity
03/16/2000CA2340686A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
03/15/2000EP0985047A2 Somatic gene therapy to suppress secondary cataract formation
03/15/2000EP0985046A1 A soluble vaccinia virus protein that binds chemokines
03/15/2000EP0985035A2 Dna methyltransferase genomic sequences and antisense oligonucleotides
03/15/2000EP0985028A2 Transplants for myocardial scars and method and cellular preparations therefor
03/15/2000EP0984986A2 Human type 3 ryanodine receptor protein and dna molecules coding therefor
03/15/2000EP0984983A2 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and a kinase domain
03/15/2000EP0984925A1 Compounds, preparation and use for transferring nucleic acids into cells
03/15/2000EP0984790A1 Herpes simplex virus vp22 vaccines and methods of use
03/15/2000EP0984699A1 Method of inhibiting immune system destruction of transplanted viable cells
03/15/2000EP0434721B1 Viral nucleotide sequences
03/15/2000CN1247566A Novel peptide, novel DNA, and novel antibody
03/15/2000CN1247473A Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
03/14/2000US6037461 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/14/2000US6037329 Compositions containing nucleic acids and ligands for therapeutic treatment
03/14/2000US6037320 Neurotrophic factor (NT-4)
03/14/2000US6037176 Nucleotide sequences that are suppressors of human cell adhesion molecule gene expression; anticarcinogenic agents, antiinflammatory agents
03/14/2000US6037172 Viral transfer plasmid coding heterologous genes
03/14/2000US6037149 Nucleotide sequence coding human interleukin-9; for the diagnosis of sensitivity to allergy and asthma
03/14/2000US6037146 CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor
03/14/2000US6037134 Methods that detect compounds that disrupt receptor tyrosine kinase/GRB-7 complexes
03/14/2000US6037121 DNA sequence encoding a tumor suppressor gene
03/14/2000CA2132424C Antisense oligonucleotide inhibition of papillomavirus
03/14/2000CA2098483C Safe adeno-associated virus 2 vector for gene therapy
03/09/2000WO2000012763A1 Prostate specific regulatory nucleic acid sequences
03/09/2000WO2000012741A2 Inducible expression system
03/09/2000WO2000012740A2 ADENOVIRUSES DELETED IN THE IVa2, 100K AND/OR PRETERMINAL PROTEIN SEQUENCES
03/09/2000WO2000012738A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000WO2000012719A1 Cdc2-related kinase associated with acute leukemia
03/09/2000WO2000012710A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
03/09/2000WO2000012709A2 Phelix: a testis-specific protein expressed in cancer
03/09/2000WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
03/09/2000WO2000012702A2 Human genes differentially expressed in colorectal cancer
03/09/2000WO2000012700A1 GENE ENCODING CDw108
03/09/2000WO2000012694A1 Chromosome 1-linked prostate cancer susceptibility gene and multisite tumor suppressor
03/09/2000WO2000012693A1 Dna transfer technology for shuttling large inserts into mammalian cells
03/09/2000WO2000012691A1 Nucleic acid sequence for potentiating the expression of useful gene and method therefor
03/09/2000WO2000012689A1 Polypeptides and polynucleotides from coagulase-negative staphylococci
03/09/2000WO2000012688A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000WO2000012686A1 Expression systems for functional nucleic acid expression
03/09/2000WO2000012685A2 Genes associated with neurotransmitter processing
03/09/2000WO2000012683A2 Stem cells bearing an fgf receptor on the cell surface
03/09/2000WO2000012679A1 Novel ubiquitin ligases as therapeutic targets
03/09/2000WO2000012552A1 MAMMARY-SPECIFIC TRANSCRIPTION FACTOR BrEts
03/09/2000WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3
03/09/2000WO2000012550A1 Novel polypeptide
03/09/2000WO2000012545A2 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6
03/09/2000WO2000012535A2 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012530A1 dU SITE-DIRECTED CLEAVAGE OF COVALENT CONJUGATES
03/09/2000WO2000012525A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000WO2000012139A1 Hypoxia regulated genes
03/09/2000WO2000012133A1 Neisseria spp. polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012131A1 Multicomponent vaccines
03/09/2000WO2000012127A2 Dna cancer vaccine and methods for its use
03/09/2000WO2000012121A1 Method of dna vaccination
03/09/2000WO2000012118A2 Inhibiting cardiomyocyte death
03/09/2000WO2000012114A1 Peptide scaffolds for transfer of molecules into eukaryotic cells
03/09/2000WO2000012113A2 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012105A1 RAMP2a: RECEPTOR ACTIVITY MODIFYING PROTEIN-2a
03/09/2000WO2000012066A1 Alginate capsules for use in the treatment of brain tumour
03/09/2000WO2000012028A1 Implantable system with drug-eluting cells for on-demand local drug delivery
03/09/2000WO1999065515A3 Combination of radiotherapy and anti-angiogenic factors
03/09/2000WO1999062940A9 Methods of altering cardiac cell phenotype
03/09/2000WO1999062592A9 Flow-through electroporation system for ex vivo gene therapy
03/09/2000WO1999062548A9 Methods and compositions for diagnosing tauopathies
03/09/2000WO1999061590A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
03/09/2000WO1999060017A3 Human tumour-derived polypeptide hormone phosphatonin
03/09/2000WO1999055883A3 Triacylglycerol lipases
1 ... 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 ... 870